Multiple myeloma epidemiology and demographics

Jump to navigation Jump to search

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma epidemiology and demographics

CDC on Multiple myeloma epidemiology and demographics

Multiple myeloma epidemiology and demographics in the news

Blogs on Multiple myeloma epidemiology and demographics

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Multiple myeloma is the second most common blood cancer after non-Hodgkin's lymphoma & 15th most common cancer overall in United States.[1][2] Multiple myeloma is a disease of the elderly and is slightly more prevalent in men than women. It is estimated that 77,617 people currently live with multiple myeloma in the United States.[3]

Epidemiology and Demographics

Incidence

  • Since 1975, overall multiple myeloma incidence has increased nearly 1 percent annually.[4]
  • In 2012, the incidence of multiple myeloma is approximately 6.3 per 100,000 individuals with a case-fatality rate of 3.3 per 100,000 in the United States.[5]

Prevalance

  • Myeloma is the fourteenth leading cause of cancer death in the United States.[6]
  • There are approximately 76,000 people in the United States living with multiple myeloma. [7]
  • It represents approximately 1% of all cancers and 2% of all cancer deaths.
  • In 2012, there were an estimated 89,658 people living with multiple myeloma in the United States.[8]

Age

  • Multiple myeloma is the second most prevalent blood cancer (10%) after non-Hodgkin's lymphoma. Although the peak age of onset of multiple myeloma is 65 to 70 years of age, recent statistics report increasing incidence as well as earlier age of onset of multiple myeloma.

Gender

  • Multiple myeloma affects slightly more men than women.

Race

  • African Americans and non Hispanics have the highest reported incidence of multiple myeloma in the United States while Asians and American Indians have the lowest
  • Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer death. [9]

References

  1. Collins, CD. (2005). "Problems monitoring response in multiple myeloma". Cancer Imaging. 5 Spec No A: S119–26. doi:10.1102/1470-7330.2005.0033. PMID 16361127.
  2. "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
  3. "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
  4. A snapshot of myeloma. National cancer institute(2014)http://www.cancer.gov/research/progress/snapshots/myeloma
  5. Plasma cell neoplasm.National cancer institute (2015)http://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq#cit/section_1.1
  6. Seer stat fact sheet:Myeloma. http://seer.cancer.gov/statfacts/html/mulmy.html
  7. "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
  8. Seer stat fact sheet:Myeloma. http://seer.cancer.gov/statfacts/html/mulmy.html
  9. "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.

Template:WikiDoc Sources